Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Hair can be used to measure cancer-related chemicals noninvasively.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

New inhibitors may reduce gut toxicity from cancer drugs.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

A truncated protein linked to breast cancer may change cell adhesion.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Sentinel lymph node mapping is safe and effective for early-stage ovarian cancer but isn't yet standard practice.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Dutasteride may help shrink prostate cancer tumors.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.